12/18/2024 4:01 PM | Monopar Therapeutics (Filer)
| Form 424B3 | |
12/17/2024 11:15 PM | Monopar Therapeutics (Filer)
| Form EFFECT | |
12/06/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/29/2024 4:01 PM | Monopar Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
11/08/2024 7:02 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2024 7:01 AM | Monopar Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024 2:13 PM | JANUS HENDERSON GROUP PLC (Filed by) Monopar Therapeutics (Subject)
| Form SC 13G | |
|
10/31/2024 3:17 PM | Monopar Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
10/28/2024 3:04 PM | Monopar Therapeutics (Filer)
| Form 424B5 | |
10/28/2024 5:00 AM | ASTRAZENECA PLC (Filed by) ASTRAZENECA PLC (Filed by) Monopar Therapeutics (Subject)
| Form SC 13G | |
10/24/2024 3:08 PM | Monopar Therapeutics (Subject) TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
10/24/2024 6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/22/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/15/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/07/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2024 6:45 PM | Monopar Therapeutics (Issuer) Robinson Chandler (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2024 6:44 PM | Cittadine Andrew (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/27/2024 3:07 PM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/21/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2024 7:01 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2024 7:02 AM | Monopar Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/22/2024 6:00 AM | Monopar Therapeutics (Filer)
| Form DEF 14A | |
07/22/2024 6:01 AM | Monopar Therapeutics (Filer)
| Form ARS | |
07/11/2024 3:30 PM | Monopar Therapeutics (Filer)
| Form PRE 14A | |
07/09/2024 3:01 PM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2024 5:20 PM | Monopar Therapeutics (Issuer) Radhakrishnan Karthik (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/03/2024 5:22 PM | Monopar Therapeutics (Issuer) Radhakrishnan Karthik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:07 PM | Monopar Therapeutics (Issuer) Robinson Chandler (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:08 PM | Monopar Therapeutics (Issuer) Tsuchimoto Kim R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:12 PM | Cittadine Andrew (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2024 4:16 PM | Cittadine Andrew (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 5:08 PM | Cittadine Andrew (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 6:30 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2024 5:12 PM | Cittadine Andrew (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 3:56 PM | Cittadine Andrew (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:10 PM | Monopar Therapeutics (Issuer) Robinson Chandler (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad) The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget!
We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] |
05/09/2024 6:00 AM | Monopar Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/16/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 7:33 PM | Monopar Therapeutics (Issuer) Robinson Chandler (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 7:33 PM | Monopar Therapeutics (Issuer) Tsuchimoto Kim R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 7:35 PM | Cittadine Andrew (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 6:01 AM | Monopar Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/07/2024 7:30 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 12:45 PM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 5:59 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 6:36 PM | Monopar Therapeutics (Issuer) Robinson Chandler (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:37 PM | Monopar Therapeutics (Issuer) STARR CHRISTOPHER M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:38 PM | KLAUSNER ARTHUR J (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:39 PM | Cittadine Andrew (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:40 PM | Brown Michael J (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:40 PM | Anderson Raymond (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:33 PM | Monopar Therapeutics (Issuer) RIOUX PATRICE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:34 PM | Monopar Therapeutics (Issuer) Tsuchimoto Kim R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |